SYN Stock Price, News & Analysis
Company Description
SYN (NYSE: SYN) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $16.2M.
SYN stock has gained 130.3% over the past year.
This page provides a comprehensive overview of SYN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SYN (SYN) stock. Over the past 12 months, the stock has gained 130.3%. At a market capitalization of $16.2M, SYN is classified as a micro-cap stock with approximately 15.8M shares outstanding.
Latest News
SYN has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include management, clinical trial, earnings, conferences, private placement. View all SYN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SYN Company Profile & Sector Positioning
SYN (SYN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing SYN often look at related companies in the same sector, including Edesa Biotech Inc (EDSA), Cellectar Biosciences Inc (CLRB), Tharimmune Inc (THAR), MetaVia Inc (MTVA), and Longeveron Inc (LGVN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SYN's relative position within its industry.